Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055471
Status:
COMPLETED
Last Update Posted:
2012-10-31
First Post:
2003-03-03
Brief Title:
A Phase IIa Open-label Multicenter Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 Zibotentan Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
4054IL0004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None